• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.

作者信息

Keramida Kalliopi, Farmakis Dimitrios, Rakisheva Amina, Tocchetti Carlo Gabriele, Ameri Pietro, Asteggiano Riccardo, Barac Ana, Bax Jeroen, Bayes-Genis Antoni, Bergler Klein Jutta, Bucciarelli-Ducci Chiara, Celutkiene Jelena, Coats Andrew J S, Cohen Solal Alain, Dent Susan, Filippatos Gerasimos, Ghosh Arjun, Hermann Joerg, Koop Yvonne, Lenihan Daniel, Lopez Fernandez Teresa, Lyon Alexander R, Mercurio Valentina, Moura Brenda, Piepoli Massimo, Sener Yusuf Ziya, Suter Thomas, Sverdlov Aaron L, Tadic Marijana, Thum Thomas, van der Meer Peter, van Linthout Sophie, Metra Marco, Rosano Giuseppe

机构信息

Cardiology Department, General Anti-Cancer Oncological Hospital Agios Savvas, Athens, Greece.

Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens Medical School, Athens, Greece.

出版信息

Eur J Heart Fail. 2024 Oct;26(10):2077-2093. doi: 10.1002/ejhf.3412. Epub 2024 Aug 28.

DOI:10.1002/ejhf.3412
PMID:39193837
Abstract
摘要

相似文献

1
The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.癌症患者的右心。欧洲心脏病学会心力衰竭协会（HFA）和欧洲心脏病学会心脏肿瘤学委员会的科学声明。
Eur J Heart Fail. 2024 Oct;26(10):2077-2093. doi: 10.1002/ejhf.3412. Epub 2024 Aug 28.
2
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).心血管影像学在接受心脏毒性治疗的癌症患者中的作用：代表心力衰竭协会（HFA）、欧洲心血管影像协会（EACVI）和欧洲心脏病学会心脏肿瘤学委员会（ESC）的立场声明。
Eur J Heart Fail. 2020 Sep;22(9):1504-1524. doi: 10.1002/ejhf.1957. Epub 2020 Aug 21.
3
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.癌症免疫治疗的心血管毒性——欧洲心脏病学会心力衰竭协会（HFA）和欧洲心脏病学会心血管肿瘤学理事会的科学声明。
Eur J Heart Fail. 2024 Oct;26(10):2055-2076. doi: 10.1002/ejhf.3340. Epub 2024 Aug 1.
4
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.血清生物标志物在接受心脏毒性癌症治疗的癌症患者中的作用：心力衰竭协会的心脏肿瘤学研究小组和欧洲心脏病学会的心脏肿瘤学理事会的立场声明。
Eur J Heart Fail. 2020 Nov;22(11):1966-1983. doi: 10.1002/ejhf.2017. Epub 2020 Oct 20.
5
Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee: Developed in collaboration with the European Heart Rhythm Association (EHRA), the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC, the Heart Failure Association (HFA) of the ESC, the ESC Young Community, the ESC Working Group on e-Cardiology, the ESC Council for Cardiology Practice, the ESC Council of Cardio-Oncology, the ESC Council on Hypertension, the ESC Patient Forum, the ESC Digital Health Committee, and the European Association of Preventive Cardiology (EAPC).支持采用移动健康解决方案的证据的标准化评估：欧洲心脏病学会监管事务委员会的临床共识声明：与欧洲心律协会（EHRA）、欧洲心脏病学会心血管护理与相关专业协会（ACNAP）、欧洲心脏病学会心力衰竭协会（HFA）、欧洲心脏病学会青年社区、欧洲心脏病学会电子心脏病学工作组、欧洲心脏病学会心脏病学实践委员会、欧洲心脏病学会心脏肿瘤学委员会、欧洲心脏病学会高血压委员会、欧洲心脏病学会患者论坛、欧洲心脏病学会数字健康委员会以及欧洲预防心脏病学协会（EAPC）合作制定。
Eur Heart J Digit Health. 2024 Jun 4;5(5):509-523. doi: 10.1093/ehjdh/ztae042. eCollection 2024 Sep.
6
Corrigendum to 'Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)' [Eur J Heart Fail 2020;22:1504-1524].《心血管成像在接受心脏毒性治疗的癌症患者中的作用：代表心力衰竭协会（HFA）、欧洲心血管成像协会（EACVI）和欧洲心脏病学会（ESC）心脏肿瘤学委员会的立场声明》勘误 [《欧洲心力衰竭杂志》2020年；22:1504 - 1524]
Eur J Heart Fail. 2021 Feb;23(2):345. doi: 10.1002/ejhf.2153.
7
The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity.新型 HFA/ICOS 风险评估工具，用于识别慢性髓性白血病患者发生心脏毒性的高危风险。
ESC Heart Fail. 2022 Jun;9(3):1914-1919. doi: 10.1002/ehf2.13897. Epub 2022 Mar 31.
8
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry.更新的 2018 年 HFA-ESC 晚期心力衰竭定义的预后影响：来自 HELP-HF 登记处的结果。
Eur J Heart Fail. 2022 Sep;24(9):1493-1503. doi: 10.1002/ejhf.2561. Epub 2022 May 31.
9
The added value of the HFA/ICOS score in the prediction of chemotherapy-related cardiac dysfunction in breast cancer.HFA/ICOS 评分在预测乳腺癌化疗相关心脏功能障碍中的附加价值。
J Cardiovasc Med (Hagerstown). 2024 Mar 1;25(3):218-224. doi: 10.2459/JCM.0000000000001589. Epub 2024 Feb 2.
10
Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of Cardiology.介入心脏病学在癌症患者中的应用：来自葡萄牙心血管介入协会和葡萄牙心脏病学会葡萄牙心血管肿瘤研究小组的立场文件。
Rev Port Cardiol. 2024 Jan;43(1):35-48. doi: 10.1016/j.repc.2023.04.013. Epub 2023 Jul 22.

引用本文的文献

1
Cardiotoxicity in Elderly Breast Cancer Patients.老年乳腺癌患者的心脏毒性
Cancers (Basel). 2025 Jun 30;17(13):2198. doi: 10.3390/cancers17132198.
2
Impact of oncologic diseases on outcome in patients with severe isolated tricuspid regurgitation.肿瘤疾病对重度单纯三尖瓣反流患者预后的影响。
Eur J Clin Invest. 2025 Mar;55(3):e14367. doi: 10.1111/eci.14367. Epub 2024 Dec 2.